NYD's Profile
Displaying 1-50 of 777 result(s).
Recent Articles
- Mereo BioPharma Group plc Faces Scrutiny Over Investment Concerns
- AMD Stock Sees Surge on AI Chip Pricing Adjustments
- Unicycive Therapeutics Faces Legal Scrutiny from Investors
- Understanding China's Economic Resilience Amidst Global Challenges
- Investigation into Necessity Retail REIT: What Investors Should Know
- Major Donation Fuels Breakthrough Research in Stuttering Treatment
- Innovative System Designed to Manage Crawl Space Water Problems
- Coco Robotics Integrates Autonomous Delivery with White Castle
- Harin Shetty Joins West Monroe to Foster Innovation and Growth
- Innovative Partnership Launches Rapidise with $4M Funding
- Ekinops Reports Strong 2025 Results with Increased Margins
- Sequana Medical Announces Key Shareholder Transparency Trends
- TELUS and Welch's Form Innovative Partnership for Food Compliance
- Centric Software Unveils Innovative Mobile PLM for Teams
- Vicat H1 2025: Resilience Amid Economic Turmoil
- Levine Leichtman Capital Partners Expands Portfolio with Shipley
- Declining Trust in U.S. Food Safety: A Rising Concern Among Americans
- Growth Outlook for the Asphalt Additives Market by 2031
- Global Automotive Seals Market Forecast and Key Insights
- Growth Projections for the Sprayed-in-Place Pipe Industry
- Exploring the Future of the Aircraft Pumps Market Through 2034
- Investors Alert: Class Action Lawsuit Against RxSight, Inc.
- Optimism Surges for American Airlines Despite Earnings Concerns
- Ransomware Threats Surge: Insights from Q2 2025 Analysis
- Pomerantz Law Firm Looks Into Investor Claims Against Dow Inc.
- Easterly ROCMuni Bond Fund Class Action Lawsuit Updates
- Fiserv Inc. Faces Class Action as Investors Respond to Stock Decline
- Geely Automobile Holdings Under Investigation for Fraud Claims
- NACON Achieves Impressive €31.3 Million Sales in Q1 2025
- Legal Investigation into MarineMax's Business Practices
- ASM International Completes Significant Share Buyback Program
- EssilorLuxottica's Impressive Q2 Growth and AI Innovations
- The Growth Journey of Ascendis Pharma Over the Past Decade
- Bolloré SE Challenges AMF Decision on Vivendi Buyout Offer
- Replimune Group Faces Class Action Amid Stock Price Drop
- UES Enhances Reach with Strategic Acquisition of GME Testing
- Investigation into Dyne Therapeutics' Business Practices and Fraud
- Investigation Insights on GSK plc and Investor Impact
- ASM International Completes €150 Million Share Buyback Program
- Investing Insights: The Future of Nutex Health Inc. Explained
- Pomerantz Law Firm's Investigation into ZEEKR Technology Investors
- Understanding Market Trends Through Tech Giants' Earnings
- Rexel Unveils Comprehensive Financial Insights for H1 2025
- Diving Into Graphic Packaging's Impressive 15-Year Growth
- Tevogen.AI Celebrates U.S. AI Action Plan Advancements
- CervoMed Announces Positive Progress in Dementia Treatment Study
- Transform Your Investment: The Power of Compounding with AEM
- Hengrui Pharma and GSK Forge $12 Billion Partnership for Innovation
- Revvity Inc. Adjusts 2025 Outlook Amid Diagnostics Challenges
- Enterprise Products Partners Reports Strong Earnings and Growth Plans
